These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3899024)

  • 41. [Clinical and laboratory evaluations of ceftazidime in perinatal use. A study of ceftazidime in the perinatal co-research group].
    Matsuda S; Kashiwakura T; Suzuki M; Shimizu T; Sengoku K; Mure K; Sagawa T; Ichinohe K; Fujimoto S; Akahane M
    Jpn J Antibiot; 1986 Aug; 39(8):2199-213. PubMed ID: 3540351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [New antimicrobial agent series IL: cefepime].
    Hara K
    Jpn J Antibiot; 1996 Aug; 49(8):766-81. PubMed ID: 8910134
    [No Abstract]   [Full Text] [Related]  

  • 43. Topical use of ceftazidime in gram negative pulmonary pathologies.
    Barberis S; Cristaldi G; Galietti F; Giorgis GE; Massaglia GM
    Panminerva Med; 1985; 27(4):189-94. PubMed ID: 3913889
    [No Abstract]   [Full Text] [Related]  

  • 44. Local and general treatment with ceftazidime as monotherapy in central nervous system infections and in septicemic infection.
    Fiori GP; Dietz A; Montanari M; Torre D
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):326-8. PubMed ID: 3894254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Empirical antibiotic therapy and ceftazidime].
    Modai J
    Presse Med; 1988 Oct; 17(37):1977-80. PubMed ID: 2973601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of a new beta-lactam antibiotic, ceftazidime, in the neurosurgical intensive care unit. Preliminary observations].
    Ravelli V; Buonaguidi R; Lutzemberger L
    Minerva Anestesiol; 1985 Sep; 51(9):471-3. PubMed ID: 3913880
    [No Abstract]   [Full Text] [Related]  

  • 47. Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Brogden RN
    Drugs; 1985 Feb; 29(2):105-61. PubMed ID: 3884319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fundamental and clinical evaluation of ceftazidime in the perinatal period].
    Matsunami K; Itoh T; Takada Y; Itoh K; Hayasaki M; Noda K
    Jpn J Antibiot; 1986 Aug; 39(8):2247-62. PubMed ID: 3540355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of peritoneal infection in continuous ambulatory peritoneal dialysis with ceftazidime].
    Ryckelynck JP; Hurault de Ligny B; Vergnaud M; Dapogny C; Batho JM; Landru I
    Therapie; 1987; 42(1):37-9. PubMed ID: 3296299
    [No Abstract]   [Full Text] [Related]  

  • 50. Susceptibility of clinical isolates to cephalosporins.
    Rattan A
    Indian Pediatr; 1989 Sep; 26(9):965-6. PubMed ID: 2699321
    [No Abstract]   [Full Text] [Related]  

  • 51. [A pharmacokinetic and clinical evaluation of ceftazidime in neonates and premature infants. A study of ceftazidime in the perinatal co-research group].
    Fujii R; Hashira S; Arimasu O; Fujita K; Murono K; Sakata H; Kakehashi H; Oka T; Kaeriyama M; Yoshioka H
    Jpn J Antibiot; 1986 Aug; 39(8):2048-67. PubMed ID: 3540339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of ceftazidime in the treatment of osteomyelitis and osteoarthritis.
    De Bastiani G; Nogarin L; Molinaroli F; Bragantini A; Fostini R
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):677-9. PubMed ID: 3546169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Assessment of the efficacy of treating infections in hematopoietic proliferative diseases: Monotherapy with ceftazidime and tobramycin combined with amoxycillin/ampicillin].
    Koehler M; Bubała H; Sońta-Jakimczyk D; Wieczorek M; Janik-Moszant A; Kuder K
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):417-20. PubMed ID: 2267192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical and pharmacokinetic evaluation of ceftazidime in neonates and young infants].
    Fujita K; Murono K; Sakata H; Kakehashi H; Oka T; Kaeriyama M; Yoshioka H; Maruyama S; Sanae N; Inyaku F
    Jpn J Antibiot; 1986 Aug; 39(8):2068-76. PubMed ID: 3540340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetic and clinical evaluation of ceftazidime in neonates and premature infants].
    Sunakawa K; Ishizuka Y; Iwata S; Sato Y; Oikawa T
    Jpn J Antibiot; 1986 Aug; 39(8):2097-107. PubMed ID: 3540343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reevaluation of current antimicrobials. Ceftazidime].
    Urabe A; Inamatsu T
    Jpn J Antibiot; 1994 Aug; 47(8):983-90. PubMed ID: 7523743
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical experience with ceftazidime in the infectious disease of children].
    Nagamatsu I; Horiguchi S
    Jpn J Antibiot; 1984 Mar; 37(3):338-43. PubMed ID: 6376846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fundamental and clinical studies on ceftazidime in the field of paediatrics].
    Nakamura T; Seto S; Kimura K; Sato K; Sato H; Fukuda F; Nishikawa S
    Jpn J Antibiot; 1984 Mar; 37(3):485-9. PubMed ID: 6376857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The treatment of bacterial infections of the lower respiratory tract in childhood. An open comparative study of sulbactam/ampicillin vs. ceftazidime].
    Longo L; Pugliese A; Schiavone R; Fumarola L; Federici S; De Lucia MG; Canale MP
    Clin Ter; 1990 Dec; 135(5):373-7. PubMed ID: 2150368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.